A new antibiotic, polyketomycin, was isolated from the culture broth of Streptomyces sp. MK277-AF1. The structure was determined by various NMR spectroscopies, X-ray crystallographic analysis and degradation experiments.
In the course of our screening program for novel antibiotics, we have found polyketomycin
(1) from the culture broth of Streptomyces sp. MK277-AF1. In the preceding paper, the taxonomy of the producing strain, production, isolation, pysico-chemical properties and biological activities of 1 are reported1). In this paper, we describe the structure determination of 1 (Fig. 1 ).
Results and Discussion
Structure Elucidation Polyketomycin (1) was obtained as an orange powder.
The UV spectrum of 1 showed absorption maxima at 208, 243, 282 and 445nm. The visible absorption band exhibited characteristic bathochromic shifts in alkaline solution. This UV spectrum was very similar to that of dutomycin2). The IR spectrum of 1 indicated the presence of hydroxyl, ester and quinone groups at 3430, 1680 and 1635cm-1, respectively.
The molecular formula of 1 was deduced as C44H48O18
(MW 864) from the FAB-MS peaks at m/z 865 (M+H)+ and m/z 864 (M-), and from HRFAB-MS [found m/z 864.2831 (M-), calcd. m/z 864.2841 for C44H48O18], which was supported by the 1H and 13C NMR spectra of 1 (Table 1) . The 13C NMR, DEPT and HMQC spectra of 1 revealed the presence of twenty-two sp3 carbons consisting of seven methyl, a methoxy, four methylene, seven methine and three quaternary carbons. In addition, I contained twenty-two sp2 carbons consisting of three methine and nineteen quaternary carbons. The 1H NMR spectrum indicated the presence of six exchangeable hydroxyl groups in addition to the protons described These degradation studies were consistent with the structure of 1 which was elucidated from the NMR data.
The structure of polyketomycin is similar to the structure of dutomycin. The difference between polyketomycin and dutomycin is ascribed to the dimethylsalicyloyl moiety. Thus, the relative structure of polyketomycin (1) was determined to be 4-[O-2, 6-dideoxy-4-O-(2-hydroxy-3, 6-1, 2, 3, 4, 4a, 5, 7, 10, 12, 12a-decahydro-4a, 11, 12a-trihydroxy-2-(1-hydroxymethylidene)-8-methoxy-6-methylnaphthacene-1, 3, 7, 10, 12-pentaone. A suspension of 1 (280mg) in 0.01N HCl-MeOH (15ml) was stirred at room temperature for 24 hours. The reaction mixture was filtered and the precipitate was washed with MeOH. The precipitate was dried under reduced pressure to give aglycone 2 (119.6mg) as a red powder. The filtrate was concentrated to a small volume after neutralization with 0.1M NaHCO3. The concentrate was mixed with CHCl3 (100ml) and H2O (100ml). The
CHCl3 layer was concentrated and the residue was purified by silica gel column chromatography (Wakogel C-200, 18g; n-hexane-EtOAc, 3:1) to give 5a (11.9mg) as a colorless syrup and a crude mixture of compounds containing 3a, 3b, 4a, 4b and 5b. The crude compounds were further purified by silica gel TLC (Merck Kieselgel 60F254, n-hexane-EtOAc, 3:1) to give 3a (9.4mg), 3b
(1.7mg), 4a (2.7mg), 4b (<0.1mg) and 5b (9.6mg) as colorless syrups. Methanolysis (0.1N HCl-MeOH) of 3a gave 4a, 5a and 5b, which were identical with the samples obtained from 1. Table 2 . Crystal data of 2.
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